Enterprise Value

2.261B

Cash

135.7M

Avg Qtr Burn

-15.63M

Short % of Float

13.90%

Insider Ownership

6.24%

Institutional Own.

46.86%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
VK2809 (THR-B agonist) Details
Non-alcoholic steatohepatitis

Big Mover™

Susp. Mover™

Phase 2b

Data readout

VK5211 (SARM) Details
Muscle injury following hip fracture

Phase 2

Update

Phase 2

Initiation

Phase 1b

Update

Phase 1

Data readout